Onchocerciasis is one of the neglected tropical diseases; it is produced by the filarial nematode Onchocerca volvulus and is transmitted through the bites of infected black flies of the Simulium genus. It is considered the second leading cause of preventable blindness and is present in 35 countries on three continents: Africa, America, and Asia. The following three countries have been declared free from onchocerciasis: Colombia, Ecuador, and Mexico. The main clinical manifestations are dermatological and ocular; however, lymphatic and neurological alterations have also been described. Diagnosis is made by identification of microfilariae in skin or sclerocorneal biopsy, by nodulectomy in search of adult worms, or by using a slit lamp to observe the parasite in the eye. There is pharmacological treatment through the use of ivermectin or surgical treatment by direct removal of adult nematodes from the onchocercomas. World programs are based on vector control and drug therapy. Despite current knowledge and global efforts, onchocerciasis remains a serious public health issue and an important cause of disability. Thus, an update on the topic is warranted.